جست‌وجوی استاد و پژوهشگر

Benjamin Jungمشاهده پروفایل

استاد

• Strategic Management
• Business Model Innovation
• Automotive Industry Transformation
• +۴ مورد دیگر

Prof. Dr. Benjamin Jung is a Professor of Industrial Engineering, specializing in Business Management at the Osnabrück University of Applied Sciences. He holds a doctoral degree (Dr. rer. pol.) from the University of Duisburg-Essen and has extensive industry experience as Managing Director at Heitkamp & Thumann Group. His research focuses on strategic decisions in radical technological transitions, particularly in the automotive and healthcare sectors. He leads the Faculty of Management, Culture and Technology and serves as the Startup Coordinator. Education & Career: PhD from University of Duisburg-Essen (2010-2014), RWTH Aachen (Industrial Engineering degree with international studies in Lille). Industry roles include Managing Director at H&T Tool Design and H&T Production Technology (2019-2021), Program Manager for Connected Devices at H&T Presspart (2016-2019), and Executive Education at ESMT Berlin, Darden School of Business, and CKGSB. Research Focus: Strategic decisions in corporate boundary decisions during technological shifts, portfolio models for corporate strategy, and strategy implementation practices. Key areas include automotive industry transformation towards electromobility and connected medical device innovations in respiratory care. Publications: Over 20 peer-reviewed articles and patents focusing on automotive business models, NPV traps in innovation portfolios, and connected inhaler technology. Recent work analyzes EV sales impact on automaker valuations and strategic challenges in mobility transitions. Roles: Professor at Osnabrück University (since 2022), Startup Coordinator for Faculty, Adjunct Lecturer at Professional School. Previously: Assistant to Managing Board at Heitkamp & Thumann Group (2014-2016), Research Assistant at Duisburg-Essen University's Automotive Management Chair (2010-2013).

• Dendrimers
• Luminescence
• Green Chemistry
• +۶ مورد دیگر

Vasco Bonifácio is an Assistant Professor at the Department of Bioengineering, Instituto Superior Técnico (IST), Lisbon, Portugal. He is affiliated with the Institute of Bioengineering and Biociences (INEB) and the Scientific Area of Biomaterials, Nanotechnology, and Regenerative Medicine. His research focuses on dendrimers, luminescent materials, green chemistry, mechanochemistry, and cancer theranostics. He teaches Biomolecular Engineering, Biomaterials Technology, and Integrative Biotechnology Projects. Bonifácio leads funded projects in cancer therapy, regenerative medicine, and drug delivery, including collaborations with Merck and AMGEN. He supervises PhD students in cancer metabolism, nanotherapeutics, and exosome engineering, and MSc students in protein stabilization. His scientific contributions include pioneering work on polyurea dendrimers for targeted drug delivery, mechanochemical synthesis of biometallic complexes, and sustainable molecularly imprinted polymers. He has developed novel dry powder formulations for pulmonary delivery and engineered exosomes for amyloid-beta clearance. Awards include the Outstanding Teaching Award (IST Pedagogical Council) and the Advanced Materials Scientist Medal (IAAM). Bonifácio's lab integrates nanomedicine, materials science, and sustainable chemistry. Key projects include tackling ovarian cancer chemoresistance via BSO nanodelivery and developing smart nanocarriers for targeted therapies. He also innovates in accessible science education for visually impaired users through tools like NavMol software.

• Pharmaceutical Sciences
• Pharmaceutics
• Drug Delivery
• +۴ مورد دیگر

Dr. Waseem Kaialy is a Senior Lecturer in Pharmaceutics at the School of Pharmacy, Faculty of Science and Engineering, University of Wolverhampton. He earned his BPharm (2007) with five Academic Excellence Awards, followed by a PhD in Pharmaceutics from the University of Kent (2013) in collaboration with Pfizer Ltd. His academic journey includes roles as a pharmacy manager (2007-2008), teaching assistant (2008-2009), postdoctoral research associate (2013-2014) at Kent, and visiting researcher at Luleå University of Technology (Sweden). Education: BPharm (2007), PhD (2013), PGC Academic Practice in Higher Education (2014-2015) Certification: AoFAQ Level 3 Award in First Aid at Work (2016) Dr. Kaialy’s research focuses on enhancing drug delivery systems through particle engineering, with emphasis on: Optimizing aerosolization performance of dry powder inhalers Improving solubility and dissolution rates of poorly soluble drugs Enhancing flowability and tabletability of poorly compactible drugs His work spans pharmaceutical solid-state properties, triboelectrification effects, and lyophilization techniques, with over 90 publications, 1331 citations, and leadership roles in editorial boards for 25 journals. Notable scientific awards include the ERAS Fellowship and Fellowship of the Higher Education Academy . Dr. Kaialy has supervised multiple research-based degrees at Wolverhampton, focusing on composite particle engineering and novel formulation strategies.

Qingguo Xuمشاهده پروفایل

استاد

• Drug Delivery
• Nanotechnology
• Materials Science
• +۶ مورد دیگر

Qingguo Xu, D.Phil., is a Blick Scholar Professor of Pharmaceutics at Virginia Commonwealth University (VCU), with joint appointments in Biomedical Engineering, Ophthalmology, Pediatrics, and the Massey Cancer Center. He holds a D.Phil. in Materials Science from the University of Oxford and degrees in Polymer Materials and Engineering from Tianjin University. Dr. Xu's research focuses on materials science, drug delivery, and nanotechnology, particularly targeting ocular, pulmonary, and opioid use disorder therapies. His work involves physiochemical characterization of mucosal barriers and translational medical research. 2018 Powe Junior Faculty Award 2019 CRS Ocular Delivery Young Investigator 2024 CAB-Mid-Career Investigator Award 2019-2024 VCU Blick Scholar 2023 VCU National/International Recognition Award (NIRA) His lab has secured ~$10 million in NIH and FDA grants, developed >15 patents, and pioneered methods for safe, effective drug delivery to treat eye diseases, lung infections, and opioid addiction. Current projects include sustained-release microparticles, nanoparticle-based therapies, and inhalable formulations. His research addresses mucosal barrier challenges via muco-penetrating particles and biomaterials engineering.

Afzal-Ur-Rahman Mohammedمشاهده پروفایل

استاد

• Pharmaceutics
• Orally Disintegrating Tablets
• Nanomedicine Formulation
• +۴ مورد دیگر

Afzal-Ur-Rahman Mohammed is a Professor in Pharmaceutics at Aston University, UK, affiliated with the Aston Pharmacy School and the Pharmaceutical & Clinical Pharmacy Research Group (PCPRG). He leads the College of Health and Life Sciences and holds roles such as Director of Research (Pharmaceutical and Clinical Sciences) and Head of Pharmaceutical Sciences. His academic journey includes a PhD from Aston University (2004), MSc from Sheffield Hallam University (2001), and a Bachelor of Pharmacy (1999). Research focuses on formulation development of orally disintegrating tablets, oral liquid nanomedicines, dry particle coating technology, and buccal/intestinal absorption models. He has pioneered patents in particle coating methods and devices. Teaching responsibilities include modules on pharmaceutical formulation and drug development processes. Editorial roles include memberships on Nature Scientific Reports, Journal of Pharmaceutics, and BMC Pharmacology and Toxicology. He serves on MHRA's Pharmacy Standards Group and was a REF 2021 panel member. Over 90 research outputs include articles on drug delivery systems and virtual clinical trials.

• Biochemistry
• Protein Science
• Pharmaceutical Chemistry
• +۲ مورد دیگر

Stefano Bruno is an Associate Professor at the Department of Pharmacy, University of Parma with a focus on Biochemistry . He holds a PhD in Biochemical Sciences from the University of Turin (2002) and has been teaching since 2004, including courses like Applied Biochemistry and Clinical Biochemical Analysis across multiple degree programs. Education : 1997: MS in Pharmaceutical Chemistry, University of Parma 2002: PhD in Biochemical Sciences, University of Turin His research spans heme proteins , enzyme characterization , and pharmaceutical applications . Key areas include: Structural and functional analysis of hemoproteins (e.g., neuroglobin, cytoglobin) Development of blood substitutes via hemoglobin modifications Investigation of serine racemase and phosphoserine phosphatase in neurological contexts Protein immobilization in silica gels for functional studies His publications (70+ peer-reviewed, H-index 20) emphasize Antarctic bacterial proteins , enzymatic inhibition , and radiopharmaceutical quality control . He has supervised 8 PhD students and contributed to international conferences like the International Symposium on Blood Substitutes . Recent work includes fluorescent biosensors, NO sensing proteins, and covalent enzyme inhibitors for cancer therapy . Awards : No specific scientific awards listed. Teaching & Leadership : Active in PhD programs ( Biochemistry , Pharmaceutical Sciences ), international schools like the ULLA Summer School , and conference organization (e.g., New Challenges in Protein Science ).

• Polymorphism of drugs
• Drug-excipient interactions
• Oral controlled drug delivery matrices
• +۳ مورد دیگر

Dr. Alessandra Rossi is an Assistant Professor at the Faculty of Pharmacy, University of Parma, specializing in drug delivery systems and pharmaceutical technology. Her research focuses on polymorphism of drugs, drug-excipient interactions, oral/nasal/pulmonary delivery systems, and nano/microparticle characterization. PhD in Pure and Applied Chemistry (University of Strathclyde, 1998) Erasmus/Socrates Research Fellowship (University of Gent, 1993-1994) Novartis Pharma AG Research Fellowship (Heriot-Watt University, 1998) Key research areas include: Development of oral hydrophilic matrices for controlled drug release Characterization of nasal and pulmonary delivery systems for targeted therapies Microencapsulation and agglomeration techniques for improved bioavailability Design of dry powder inhalers and heart-targeting nanoparticle systems Application of Quality by Design in pharmaceutical development Recent publications highlight her work in Acai oil-based organogels for topical cosmetics Microparticle systems for lung-targeted antioxidants Ligand-functionalized nanocarriers for liver cancer therapy Optimization of dry powder inhalation technologies Scientific awards and fellowships: Erasmus/Socrates Research Fellowship (1993-1994) Novartis Pharma AG Fellowship (1998)

Heidi M. Mansourمشاهده پروفایل

استاد

• Pharmaceutical Sciences
• Nanotechnology
• Nanomedicine
• +۱۶ مورد دیگر

Dr. Heidi M. Mansour is a tenured Full Professor at Florida International University (FIU), affiliated with the Robert Stempel College of Public Health and Social Work (Department of Environmental Health Sciences), Herbert Wertheim College of Medicine (Department of Cellular and Molecular Medicine), and the College of Engineering (Department of Biomedical Engineering). She leads the Drug Discovery and Delivery Program at the FIU Center for Translational Science in Port Saint Lucie, Florida, and has been a faculty member since February 2022. Research Interests: Dr. Mansour's research spans pharmaceutical sciences, nanotechnology, and translational medicine, with a focus on advanced drug delivery systems. Her work emphasizes inhaled medical aerosols, microparticles, nanoparticles, controlled and sustained release systems, and transdermal delivery. She investigates therapies for cystic fibrosis, pulmonary hypertension, infectious diseases, CNS disorders, and respiratory distress syndromes using both in vitro (2D/3D human cell models, spheroids) and in vivo models. Scientific Recognition: She has been honored with multiple prestigious fellowships: Fellow, American Institute of Medical and Biological Engineering (AIMBE), 2022 Fellow, Royal Society of Chemistry (RSC), 2024 Senior Member, National Academy of Inventors (NAI), 2023 Fellow, American Thoracic Society (ATS), 2025 Fellow, Global Academy of Nanotechnology (GAN), 2025 Fellow, International Academy of Nanotechnology (IAN), 2024 Fellow, Florida Association for Nanotechnology (FAN), 2024 ATS Presidential Commendation, 2024 Grants, Editorial & Advisory Roles: Her research is supported by NIH, FDA, and industry partners. She serves on the PhRMA Foundation Scientific Advisory Committee, ISAM Executive Board, and Cystic Fibrosis Foundation Scientific Advisory Board. She is an Associate Editor of RSC Pharmaceutics and Topics Editor of Pharmaceutics , and serves on editorial boards of multiple journals including Frontiers in Drug Delivery , Current Nanomedicine , and RSC Molecular Systems Design & Engineering . Training & Leadership: Dr. Mansour has mentored 15 postdoctoral scholars and graduated 5 PhD students. She previously served as Director of the PharmD/PhD dual-degree program and Pharmaceutics/Pharmacokinetics Track at the University of Arizona. She has co-edited two major books and published over 130 peer-reviewed articles and 17 book chapters. Laboratory & Conferences: She leads the Mansour Lab , focused on inhalation aerosols and nanomedicine. She is organizing the NanoFlorida 2025 Conference at FIU, highlighting her leadership in the nanotechnology community.

• Discrete Element Method (DEM) Simulations
• Computational Fluid Dynamics (CFD)
• Triboelectric Charging
• +۴ مورد دیگر

Francesca Orsola Alfano is a Researcher at the Department of Computer Engineering, Modeling, Electronics and Systems at the University of Calabria (UNICAL). She holds a research grant and contributes to academic programs in Chemical Engineering through her teaching activities. Current role: Research Grant Holder Teaching: Instrumentations and Analysis of Data, Chemical Process Dynamics and Control Her research focuses on computational modeling of particulate systems, particularly through Discrete Element Method (DEM) and CFD-DEM simulations . Key areas include: Triboelectric charging in powder handling Electrostatic interactions in fluidized beds Deagglomeration mechanisms in dry powder inhalers (DPI) Swirl-based particle dispersion Carrier-wall collision dynamics Polydisperse systems Recent publications highlight trends in pharmaceutical engineering applications (e.g., DPI optimization) and electrostatic modeling for industrial particulate systems. Her work bridges chemical engineering and computational physics , with technical implementations in DEM algorithms and fluid-solid interactions .

• Drug delivery to the lung
• Formulation development for inhalation products
• Dry powder inhalers
• +۷ مورد دیگر

Dr. Khaled H Assi serves as an Associate Professor at the University of Bradford within the School of Pharmacy & Medical Sciences, which is part of the Faculty of Life Sciences. His academic career at Bradford has spanned over two decades, beginning with his PhD completion in pharmaceutical analysis in 1999. Dr. Assi's research primarily focuses on drug delivery to the lung, encompassing formulation development for inhalation products. His work involves creating new formulations for inhaled products including dry powder, nanosuspension, and nanoemulsion for both dry powder inhalers and nebulisers. He investigates the effect of adhesion and cohesion energy on DPI formulations and determines in-vitro characteristics of inhaled products. Additionally, he researches pharmaceutical and bioanalytical assay methods, including optimization and validation of techniques for qualitative and quantitative determination of inhaled drugs in aqueous and biological fluids. As an educator, Dr. Assi teaches MPharm students at various levels and leads the MSc Pharmaceutical Technology and Medicines Control programme. The modules he delivers cover respiratory drug delivery, pharmaceutical analysis, and quality assurance and quality control of pharmaceuticals. His teaching responsibilities reflect his expertise in both theoretical and practical aspects of pharmaceutical sciences. Dr. Assi's academic journey at Bradford began with a postdoctoral position between 1999-2001 working on inhaled therapies, which was extended for an additional year through a grant from Glaxo SmithKline. He was accepted as a research fellow at Bradford School of Pharmacy in 2002, appointed as a Lecturer, and promoted to Senior Lecturer in March 2016 before achieving his current position as Associate Professor.

Karim Rafieمشاهده پروفایل

استادیار

• Virology
• Structural Biology
• Biochemistry & Molecular Biology
• +۴ مورد دیگر

Dr. Karim Rafie is an Assistant Professor in Molecular Pharmacology at the Faculty of Science and Engineering, University of Groningen. His research focuses on host-pathogen interactions, structural biology, and virology. He investigates viral entry mechanisms, enzymatic processes in posttranslational modifications (e.g., O-GlcNAc transferase), and drug delivery systems using extracellular vesicles. His work contributes to understanding infectious diseases, neurodegenerative mechanisms, and therapeutic development. Research Interests: - Structural biology of viral pathogens (e.g., adenoviruses) - Enzyme inhibitors and ligase activity modulation - Extracellular vesicle-based drug delivery - O-GlcNAc glycosylation and its biological roles Recent Articles: Dr. Rafie’s publications highlight advancements in viral capsid structure determination, enzymatic mechanisms (e.g., E3 ligases, O-GlcNAc transferase), and applications of extracellular vesicles in medicine. His 2025 studies address calcium signaling in neuronal death and inhalable dry powder formulations, reflecting his interdisciplinary approach to pharmacology and biomedicine. Labs/Teams: Affiliated with the Groningen Research Institute of Pharmacy, focusing on molecular pharmacology and structural enzymology.

Laura Urbanoمشاهده پروفایل

مدرس ارشد

• Lung Biointerfaces
• Drug Delivery Systems
• Nanoparticle Technology
• +۳ مورد دیگر

Laura Urbano is a Senior Lecturer in Pharmaceutics at the University of Hertfordshire's School of Life and Medical Sciences. She leads the institution’s involvement in the EPSRC Centre for Doctoral Training in Aerosol Sciences. Her research focuses on lung biointerfaces, including novel diagnostics, drug delivery systems, and in vitro models. She holds a PhD in Pharmaceutical Sciences from King's College London and a PGCert in Learning and Teaching in Higher Education from the University of Hertfordshire. BSc in Medical and Pharmaceutical Biotechnologies (2008–2011, University of Bari) MSc in Medical Biotechnology and Molecular Medicine (2011–2013, University of Bari) PhD in Pharmaceutical Sciences (2018, King's College London) PGCert in Learning and Teaching in Higher Education (2018–2021) Her research spans nanoparticle design, aerosol science, and photosynthesis enhancement. Notable projects include quantum dots for photosynthesis improvement and microfluidic lab-on-a-chip technologies for biomarker detection. She collaborates widely, contributing to studies on lung immune responses and aerosol interactions with lung tissues. Her recent publications highlight advancements in near-infrared imaging, phototoxicity mitigation, and intranasal vaccine formulations. She actively participates in interdisciplinary teams addressing challenges in drug delivery and environmental health impacts of atmospheric particles.

Shaokoon Chengمشاهده پروفایل

دانشیار

• Biomechanics
• Aerosol Diagnostics
• Biomedical Devices
• +۵ مورد دیگر

Shaokoon Cheng is an Associate Professor in Mechanical Engineering at Macquarie University, serving as Program Director for the Mechanical Engineering undergraduate and Master's programs. He pioneered the establishment of these programs and has led over 140 peer-reviewed publications, six patents, and significant research funding, including ARC and NHMRC grants. As Chief Technology Officer of ASKSCIENTIA, he translates research into medical technologies like aerosol diagnostics and biomedical devices. He currently supervises 9 HDR students and has guided 18 to completion, emphasizing mentorship in innovation and translation. His research focuses on biomechanics, aerosol systems, organ-on-chip technology, and thermal management. Key projects include drug delivery mechanics, organ-on-chip development, and advanced manufacturing. He holds equipment such as stereoscopic PIV, high-speed imaging systems, and optical coherence tomography. He is actively involved in professional societies like the Australian Rheological Society and Australian and New Zealand Society of Biomechanics. Education: PhD in Biomedical Engineering (UNSW), BEng (Mechanical Engineering) with First Class Honors (University of Sydney). Research Interests: Biomechanics of drug delivery, organ-on-chip devices, 3D printing for bio-applications, and aerosol flow characterization. His lab equipment includes advanced imaging and testing systems, supporting interdisciplinary projects in biomedical engineering and mechanical design. Awards: Australian Postgraduate Award (2003), Engineering Postgraduate Award (2003), International Grant (2008), Travel Awards (2009, 2011). Teaching: Focuses on improving student employability and entrepreneurship through innovative pedagogies. Projects include developing digital reality modules for fluid mechanics education.

• Pulmonology
• Allergology
• Asthma
• +۴ مورد دیگر

Jussi Karjalainen is a researcher in pulmonology and allergology with significant contributions to asthma studies, particularly in adult populations and cross-country comparisons. His work spans Finland and Sweden, focusing on asthma epidemiology, allergic responses, and respiratory drug delivery systems. Research Interests : Asthma, Allergology, Bronchoconstriction, Food Allergy, Inhaled Corticosteroids, Respiratory Disease Collaborations : Active in Finland and Sweden, with research tied to UN SDGs on health and well-being (SDG 3) and sustainable cities (SDG 11). Key Publications : 126 total outputs, including recent studies on adult asthma hospitalization trends and inhaler device optimization. Article Trends emphasize respiratory medicine, cross-national health data, and allergy-related quality of life metrics. His collaborations include academic institutions in Finland and Sweden, with notable work on methacholine challenge tests and dry powder inhalers.

Francesca Buttiniمشاهده پروفایل

دانشیار

• Pharmaceutical Technology
• Respiratory Medicine
• Drug Delivery Systems
• +۳ مورد دیگر

Francesca Buttini is an Associate Professor at the University of Parma 's Department of Food and Pharmaceutical Sciences, where she earned her PhD in 2004. She also serves as a Visiting Professor at the Institute of Pharmaceutical Science, King's College London (since 2014), and as an Affiliated Key Researcher at the Research Center Pharmaceutical Engineering GmbH in Graz, Austria (since 2016). PhD in Biopharmaceutics Pharmacokinetics (University of Parma, 2007) Degree in Pharmaceutical Science (University of Parma, 2003, cum laude ) Her research focuses on innovative pulmonary product design , including pressurized and dry powder inhalers. Her work emphasizes patient-centered approaches, addressing respiratory disease challenges through advanced drug delivery systems. She has published over 100 articles and holds 12 patents. Recent publications highlight her expertise in nasal drug delivery , neuroinflammation therapy , and COVID-19 aerosol dynamics , demonstrating interdisciplinary applications of pharmaceutical technology in respiratory and neurological fields. DDL Emerging Scientist Award (UK Aerosol Society, 2017) She founded PlumeStars , an SME developing orphan drugs for lung diseases, and serves on the Scientific Advisory Board of Alveolus Bio (US), which engineers lung-targeted probiotics. Her teaching portfolio includes Galenic Preparations Laboratory for pharmacy students since 2015/2016.